AML

Showing NaN - NaN of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • AML
  • Kansas City, Kansas
  • +8 more
Aug 3, 2022

AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)

Recruiting
  • AML
  • +2 more
  • SOC + TSC-100
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 11, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

Completed
  • AML
  • Cytarabine (Phase 1 only)
  • +3 more
  • Los Angeles, California
  • +16 more
Feb 22, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

Terminated
  • AML
  • +4 more
  • Chicago, Illinois
  • +1 more
Nov 15, 2021

AML, MDS Trial in Belgium, United States (NKR-2)

Completed
  • AML
  • MDS
  • NKR-2
  • Aurora, Colorado
  • +6 more
Apr 30, 2021

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)

Completed
  • Relapsed/Refractory AML
  • +5 more
  • Plerixafor Dose Escalation
  • Phoenix, Arizona
  • +8 more
Sep 5, 2018

Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS Trial in Worldwide (BYL719, MEK162)

Completed
  • Advanced and Selected Solid Tumors
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2017

AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))

Completed
  • AML
  • +3 more
  • STA-9090 (ganetespib)
  • Boston, Massachusetts
  • +2 more
Sep 17, 2014

AML Trial in Canada, United States (Obatoclax)

Completed
  • AML
  • Chicago, Illinois
  • +12 more
Aug 16, 2013

AML, CML, MDS Trial in New York (CYT107 - Recombinant glycosylated human interleukin 7., rhIL-7 (CYT107))

Completed
  • AML
  • +2 more
  • CYT107 - Recombinant glycosylated human interleukin 7.
  • rhIL-7 (CYT107)
  • New York, New York
    Memorial Sloan-Kettering Cancer Institute
Jul 25, 2012

Acute Myeloid Leukemia, AML Trial in Canada, Netherlands, United States (Tosedostat)

Completed
  • Acute Myeloid Leukemia
  • AML
  • Los Angeles, California
  • +20 more
Jun 27, 2012